Actual Real Exam Test Bank with 2 Currently Testing Versions
– 100 Questions Each
Introduction
This document provides two full versions of the North American Menopause Society (NAMS) Menopause
Certification Exam, each containing 100 real-style multiple-choice questions with verified answers. Re-
flecting currently testing versions as of 2025, this test bank is ideal for clinician-level certification prepa-
ration. The questions closely mirror the actual exam’s content, layout, and difficulty, aligning with
NAMS guidelines and clinical best practices for midlife women’s health.
Version 1 – 100 Questions and Answers
1. What is the median age of natural menopause in North American women?
A. 45 years
B. 51 years
C. 55 years
D. 58 years
E. 60 years
Rationale: Per NAMS, the median age of natural menopause is 51 years.
2. Which hormone declines most significantly during the menopause transition?
A. Progesterone
B. Estrogen
C. Testosterone
D. Cortisol
Rationale: Estrogen decline drives menopausal symptoms.
3. A 48-year-old woman reports irregular periods and hot flashes. What is her likely stage?
A. Premenopause
B. Perimenopause
C. Postmenopause
D. Early menopause
Rationale: Irregular periods and hot flashes indicate perimenopause, per STRAW+10.
4. What defines postmenopause clinically?
A. Onset of vasomotor symptoms
B. 12 months of amenorrhea
C. Elevated LH levels
D. Irregular menses
Rationale: Postmenopause is defined as 12 months without menstruation.
5. Which laboratory finding confirms menopause in a 53-year-old woman?
A. Low progesterone
B. Elevated FSH (>25 IU/L)
NAMS Menopause Exam Test Bank | 2 Versions | 100 Questions Each | Year 2025
, C. Normal estradiol
D. Decreased LH
Rationale: Elevated FSH confirms ovarian failure.
6. What is the most effective treatment for severe hot flashes in a healthy 50-year-old woman?
A. SSRIs
B. Hormone therapy
C. Herbal supplements
D. Gabapentin
E. Acupuncture
Rationale: Hormone therapy is most effective for vasomotor symptoms, per NAMS.
7. Which hormone therapy is recommended for a postmenopausal woman with an intact uterus?
A. Estrogen alone
B. Estrogen plus progestogen
C. Progestogen alone
D. Testosterone
Rationale: Progestogen protects the endometrium.
8. A 55-year-old woman with breast cancer history seeks hot flash relief. What is safe?
A. Estrogen therapy
B. Paroxetine
C. Progestin
D. Testosterone
Rationale: Paroxetine is FDA-approved and safe for breast cancer survivors.
9. What is an absolute contraindication for systemic hormone therapy?
A. Osteoporosis
B. Unexplained vaginal bleeding
C. Hot flashes
D. Vaginal dryness
Rationale: Unexplained vaginal bleeding requires evaluation before HT.
10. Which non-hormonal medication reduces menopausal sleep disturbances?
A. Gabapentin
B. Bisphosphonates
C. Statins
D. Diuretics
Rationale: Gabapentin improves sleep and reduces hot flashes.
11. What is the primary risk factor for osteoporosis in postmenopausal women?
A. High BMI
B. Estrogen deficiency
C. Excessive calcium
D. Sedentary lifestyle
Rationale: Estrogen deficiency accelerates bone loss.
NAMS Menopause Exam Test Bank | 2 Versions | 100 Questions Each | Year 2025
, 12. A 62-year-old woman has a T-score of -2.9. What is her diagnosis?
A. Normal bone density
B. Osteopenia
C. Osteoporosis
D. Osteomalacia
Rationale: A T-score � -2.5 indicates osteoporosis.
13. Which medication is first-line for postmenopausal osteoporosis?
A. Calcium
B. Bisphosphonates
C. Vitamin D
D. Raloxifene
Rationale: Bisphosphonates are first-line, per NAMS.
14. What is the recommended daily calcium intake for women aged 51–70 years?
A. 800 mg
B. 1000 mg
C. 1200 mg
D. 1500 mg
Rationale: NAMS recommends 1200 mg calcium daily.
15. Which medication reduces fracture and breast cancer risk?
A. Alendronate
B. Raloxifene
C. Denosumab
D. Zoledronic acid
Rationale: Raloxifene reduces fracture and breast cancer risk.
16. Which cardiovascular risk increases significantly after menopause?
A. Arrhythmias
B. Coronary artery disease
C. Heart failure
D. Mitral valve prolapse
Rationale: Estrogen loss increases coronary artery disease risk.
17. A 60-year-old woman has elevated LDL post-menopause. What is a contributing factor?
A. Increased HDL
B. Estrogen decline
C. High vitamin D
D. Low BMI
Rationale: Estrogen decline raises LDL cholesterol.
18. Which metabolic change is common in postmenopausal women?
A. Decreased triglycerides
B. Increased visceral fat
C. Improved insulin sensitivity
NAMS Menopause Exam Test Bank | 2 Versions | 100 Questions Each | Year 2025